Some people come home from a beach vacation and notice their skin looks clear and glowy. It's not their imagination. Unlike ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

He also had scaling plaques on his scalp ... Five percent to 20% of cases of cutaneous psoriasis are accompanied by psoriatic arthritis that can be debilitating. Thus, psoriasis deserves prompt ...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

Alvotech (NASDAQ:ALVO – Get Free Report) will announce its earnings results after the market closes on Wednesday, November ...

Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

Honored as Startup Technology Company of the Year, Claimable uses AI to help patients generate insurance appeals that the ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Study authors examined the use of artificial intelligence in machine learning models for the assessment of psoriasis severity, as well as identified future research needs.

If you have eczema you’ll be all too familiar with those cracked, dry, and scaly patches of skin that show up a bright red on ...